Bacillus amyloliquefaciens CECT 5940 alone or in combination with antibiotic growth promoters improves performance in broilers under enteric pathogen challenge

• Published in: Poultry science 2019-10, Vol.98 (10), p.4391-4400
• Main Authors: de Oliveira, Marllon José Karpeggiane, Sakomura, Nilva Kazue, de Paula Dorigam, Juliano Cesar, Doranalli, Kiran, Soares, Letícia, Viana, Gabriel da Silva
• Format: Article
• Language: English
• Subjects: Animal Feed - analysis; Animals; Anti-Bacterial Agents - administration & dosage; Anti-Bacterial Agents - pharmacology; Bacillus amyloliquefaciens - chemistry; Chickens; Clostridium Infections - drug therapy; Clostridium Infections - microbiology; Clostridium Infections - veterinary; Clostridium perfringens; Clostridium perfringens - physiology; Coccidiosis - drug therapy; Coccidiosis - parasitology; Coccidiosis - veterinary; Diet - veterinary; direct-fed microbial; Eimeria - physiology; Eimeria maxima; Gastrointestinal Microbiome - drug effects; Growth Substances - administration & dosage; Growth Substances - pharmacology; Immunology, Health and Disease; Male; Meat - analysis; necrotic enteritis; Poultry Diseases - drug therapy; Poultry Diseases - microbiology; Poultry Diseases - parasitology; probiotic; Probiotics - administration & dosage; Probiotics - pharmacology; Random Allocation
• ISSN: 0032-5791; 1525-3171
• DOI: 10.3382/ps/pez223

A study was conducted to investigate the effects of Bacillus amyloliquefaciens CECT 5940 as a direct-fed microbial (DFM) alone or in association with bacitracin methylene disalicylate (BMD) in broilers under enteric pathogen challenge. A total of 1,530-day-old male Cobb500 chicks were randomly assigned to 5 treatments, with 9 replicate pens with 34 birds each. Treatments included positive control (PC, basal diet without additives or challenge); negative control (NC, basal diet without additive and challenged birds); NC + 0.05 g/kg BMD; NC + 1 g/kg DFM (106 CFU B. amyloliquefaciens CECT 5940/g of feed); and NC + 0.05 g/kg BMD + 1 g/kg DFM. The challenge consisted of oral gavage with Eimeria maxima and Clostridium perfringens inoculum. Body weight gain (BWG), feed intake (FI), and feed conversion ratio (FCR) were evaluated on days 21, 35, and 42. Ileal and cecal content were collected on days 21 and 28 for C. perfringens enumeration by real-time PCR assay and the intestinal health was evaluated by scores. Uniformity (UN), carcass (CY), and breast meat yields (BMY) were evaluated on day 42. After 14 and 21 d post-inoculation, birds in the challenged groups had significant lower FI and BWG compared to the PC group (P < 0.05). However, the groups receiving DFM, BMD, or its combination presented better FCR, CY, BMY, UN, and lower incidence of footpad lesion and litter quality visual scores, compared to the NC group without feed additives (P < 0.05). Mortality was not affected by treatments (P > 0.05). Broilers fed DFM, BMD, or its combination presented lower C. perfringens in ileal content at 21 and 28 d compared to NC group without additives (P < 0.05) and also maintained gut health by keeping the frequency of ballooning, abnormal content, and swollen mucosa comparable to the PC group (P > 0.05). The study indicates that Bacillus amyloliquefaciens CECT 5940 is effective as BMD to provide similar performance and gut health in challenged broilers.